CIK: 1342826 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/5/24 16:25
11/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDM.d20.040004822269D
11/5/24 16:25
11/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.d-1773.720-48-15269D
10/2/24 17:03
10/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDM.dm20.040004822269D
10/2/24 17:03
10/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.dm-1793.750-48-15269D
9/5/24 17:10
9/3/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDM.dm20.040004822269D
9/5/24 17:10
9/3/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.dm-1924.020-48-15269D
12/16/22 17:00
12/14/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00072436D
9/28/22 17:02
9/26/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00072632D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact